Asbjørn Hróbjartsson

Medicin og biovidenskab

1. Systematic Reviews 100%
2. Randomized Controlled Trials 52%
3. Meta-Analysis 51%
4. Conflict of Interest 51%
5. Humerus 29%
6. Guidelines 27%
7. Placebos 18%
8. Publications 18%
9. Coronavirus 16%
10. Odds Ratio 15%
11. Pharmacology 13%
12. Epidemiologic Studies 12%
13. Duloxetine Hydrochloride 12%
14. Checklist 12%
15. Therapeutics 10%
16. Shoulder Fractures 10%
17. Confidence Intervals 10%
18. PubMed 10%
19. Hemiarthroplasty 9%
20. Secondary Prevention 9%
21. Shoulder 9%
22. Major Depressive Disorder 9%
23. Advisory Committees 9%
24. Clinical Studies 8%
25. Health Care Outcome Assessment 8%
26. Hydroxymethylglutaryl-CoA Reductase Inhibitors 8%
27. Patient Reported Outcome Measures 8%
28. Clinical Trials 7%
29. Coronary Disease 7%
30. Mortality 7%
31. Risk Assessment 7%
32. Mental Disorders 7%
33. Network Meta-Analysis 7%
34. Mental Health 6%
35. Industry 6%
36. Clinical Trial Protocols 6%
37. Journal Impact Factor 6%
38. Sample Size 6%
39. Medical Dictionaries 6%
40. Uterine Artery Embolization 6%
41. Research Personnel 6%
42. Data Analysis 6%
43. Anti-Bacterial Agents 5%
44. Pain 5%
45. Nutrition Policy 5%
46. Pandemics 5%
47. Cohort Studies 5%
48. Pharmaceutical Preparations 5%
49. Terminology 5%
50. Random Allocation 5%